Peer-reviewedLicence not statedJournal of the American Heart Association
Closing the Diagnostic Gap in Transthyretin Amyloid Cardiomyopathy
- 1The George Institute for Global Health, UNSW Sydney
- 2Medical University of Vienna
- 3Bayer
Related
- Diagnostic Concordance of Immediate Versus 1-Hour Technetium-99m Hydroxymethylene Diphosphonate Scintigraphy in Suspected Transthyretin Amyloid Cardiomyopathy
- Delays From Clinical Manifestations to Diagnosis of Transthyretin Amyloid Cardiomyopathy: A National Retrospective Cohort Study
- Contrasting Echocardiographic Trajectories with and Without Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy: A Real-World Observational Study with Two-Dimensional Speckle-Tracking Analysis
- Closing the diagnostic gap in transthyretin cardiac amyloidosis: red flags, modern imaging, and emerging therapies
- Efficacy of Disease-Modifying Treatments in Transthyretin Amyloid Cardiomyopathy: A Systematic Review and Meta-Analysis of Five Phase III Randomized Controlled Trials
BibTeX
@article{khanna2026closing,
title = {{Closing the Diagnostic Gap in Transthyretin Amyloid Cardiomyopathy}},
author = {Shaun Khanna and Clemens Spielvogel and Spencer Guthrie},
journal = {Journal of the American Heart Association},
year = {2026},
month = nov,
doi = {10.1161/jaha.126.055111},
url = {https://www.ahajournals.org/doi/10.1161/JAHA.126.055111},
}
RIS
TY - JOUR
TI - Closing the Diagnostic Gap in Transthyretin Amyloid Cardiomyopathy
AU - Shaun Khanna
AU - Clemens Spielvogel
AU - Spencer Guthrie
PY - 2026
DA - 2026/11/04
JO - Journal of the American Heart Association
DO - 10.1161/jaha.126.055111
UR - https://www.ahajournals.org/doi/10.1161/JAHA.126.055111
SN - 2047-9980
ER -